Andrew J Lees Selected Research

Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)

6/2015	Late Emergence of Parkinsonian Phenotype and Abnormal Dopamine Transporter Scan in Chorea-Acanthocytosis.
4/2010	Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study.
2/2010	How can neuroimaging help in the diagnosis of movement disorders?
6/2009	The use of a color coded probability scale to interpret smell tests in suspected parkinsonism.
12/2008	Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration.
7/2007	Role of DAT-SPECT in the diagnostic work up of parkinsonism.
10/2004	L-Dopa-responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew J Lees Research Topics

Disease

99	Parkinson Disease (Parkinson's Disease) 01/2022 - 09/2002
38	Parkinsonian Disorders (Parkinsonism) 01/2021 - 10/2002
20	Dyskinesias (Dyskinesia) 09/2018 - 09/2002
16	Dementia (Dementias) 01/2021 - 09/2003
15	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 07/2003
10	Tremor (Tremors) 01/2021 - 04/2003
9	Cognitive Dysfunction 01/2020 - 09/2002
8	Dystonia (Limb Dystonia) 10/2020 - 12/2002
7	Multiple System Atrophy 01/2021 - 09/2009
7	Hypokinesia (Bradykinesia) 09/2016 - 03/2003
7	Alzheimer Disease (Alzheimer's Disease) 09/2016 - 07/2003
6	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2021 - 09/2009
6	Hallucinations (Hallucination) 01/2021 - 09/2002
5	Gambling (Pathological Gambling) 11/2011 - 09/2007
4	Tauopathies 09/2016 - 04/2004
4	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 11/2012 - 09/2009
3	Dysarthria (Spastic Dysarthria) 10/2020 - 09/2002
3	Synucleinopathies 01/2016 - 11/2010
3	Frontotemporal Dementia (Semantic Dementia) 08/2015 - 10/2006
3	Disease Progression 01/2014 - 04/2006
3	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2013 - 05/2007
3	Bulimia (Binge Eating) 11/2011 - 04/2010
3	Atrophy 06/2010 - 04/2006
2	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 08/2015
2	Constipation 02/2017 - 06/2009
2	Psychotic Disorders (Schizoaffective Disorder) 08/2013 - 06/2003
2	Mania (Manias) 06/2011 - 04/2004
2	Essential Tremor (Essential Tremors) 04/2010 - 07/2007
2	Corticobasal Degeneration 10/2009 - 12/2008
2	Pain (Aches) 06/2009 - 03/2004
2	Substance-Related Disorders (Drug Abuse) 01/2009 - 05/2006
2	Paralysis (Palsy) 10/2005 - 03/2003
2	Dystonic Disorders (Writer's Cramp) 04/2005 - 06/2003
2	Tic Disorders (Tic Disorder) 10/2004 - 07/2002
1	Urinary Incontinence 01/2021
1	Consciousness Disorders 01/2021
1	Brain Diseases (Brain Disorder) 10/2020
1	Infections 10/2020
1	Nervous System Diseases (Neurological Disorders) 11/2019
1	Inflammation (Inflammations) 01/2019
1	Type 2 Episodic Ataxia 01/2018

Drug/Important Bio-Agent (IBA)

48	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 09/2002
29	Dopamine (Intropin)FDA LinkGeneric 09/2018 - 10/2002
13	Dopamine Agonists (Dopamine Agonist)IBA 01/2016 - 09/2002
12	Proteins (Proteins, Gene)FDA Link 03/2017 - 07/2003
10	SynucleinsIBA 01/2020 - 09/2007
10	Apomorphine FDA Link 12/2018 - 09/2002
7	alpha-SynucleinIBA 01/2016 - 02/2004
7	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2015 - 10/2004
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2009
6	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 06/2015 - 12/2002
6	Dopamine Agents (Dopaminergic Agents)IBA 02/2013 - 09/2002
6	Pharmaceutical PreparationsIBA 09/2011 - 07/2004
5	Cholinergic Agents (Cholinergics)IBA 01/2021 - 03/2004
5	Dihydroxyphenylalanine (Dopa)IBA 09/2018 - 10/2002
5	Protein Isoforms (Isoforms)IBA 11/2012 - 02/2004
5	UbiquitinIBA 09/2011 - 07/2003
4	opicaponeIBA 01/2022 - 02/2017
4	Amyloid (Amyloid Fibrils)IBA 01/2016 - 05/2011
4	RacloprideIBA 06/2015 - 06/2004
4	Leucine (L-Leucine)FDA Link 09/2012 - 01/2005
4	Phosphotransferases (Kinase)IBA 09/2012 - 01/2005
3	IronIBA 01/2021 - 06/2010
3	entacapone (Comtan)FDA Link 01/2018 - 09/2004
3	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 02/2017 - 01/2008
3	Antipsychotic Agents (Antipsychotics)IBA 09/2016 - 07/2002
3	Glucosylceramidase (Glucocerebrosidase)IBA 02/2013 - 06/2009
3	AntibodiesIBA 11/2012 - 10/2004
3	fluorodopa F 18IBA 11/2009 - 09/2005
2	Dopamine D3 ReceptorsIBA 12/2021 - 11/2019
2	monomethylpropion (methcathinone)IBA 10/2020 - 04/2013
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 10/2020 - 11/2019
2	BenzodiazepinesIBA 01/2018 - 09/2016
2	Botulinum Toxins (Botulinum Toxin)IBA 09/2016 - 03/2004
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2016 - 04/2007
2	Amyloid beta-PeptidesIBA 01/2016 - 04/2008
2	tau Proteins (tau Protein)IBA 06/2014 - 09/2003
2	Tolcapone (Tasmar)FDA Link 01/2014 - 01/2008
2	RNA (Ribonucleic Acid)IBA 08/2011 - 01/2004
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 04/2011 - 06/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2010 - 04/2004
2	pregnancy-associated growth factorIBA 05/2008 - 06/2007
2	Dopamine Receptors (Dopamine Receptor)IBA 04/2008 - 02/2005
2	Peptides (Polypeptides)IBA 04/2008 - 07/2007
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 05/2007 - 08/2003
2	Messenger RNA (mRNA)IBA 10/2006 - 02/2004
2	Cholinergic Antagonists (Anticholinergics)IBA 08/2003 - 06/2003
1	naxagolideIBA 12/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Biological FactorsIBA 12/2020
1	Potassium PermanganateIBA 10/2020
1	Pseudoephedrine FDA LinkGeneric 10/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018

Therapy/Procedure

33	Therapeutics 01/2022 - 09/2002
3	Deep Brain Stimulation 01/2014 - 09/2009
3	Drug Therapy (Chemotherapy) 08/2011 - 05/2010
2	Subcutaneous Injections 10/2017 - 01/2016
2	Subcutaneous Infusions 01/2016 - 11/2002
2	Denervation 02/2010 - 03/2003
1	Urinary Catheters 01/2021